Article
Permanent neonatal diabetes mellitus: same mutation, different glycemic control with sulfonylurea therapy on long-term follow-up.
Journal of clinical research in pediatric endocrinology - 1 Jun 2012
Aydin Banu Kücükemre, Bundak Rüveyde, Baş Firdevs, Maraş Hülya, Saka Nurçin, Günöz Hülya, Darendeliler Feyza
Abstract excerpt
Permanent neonatal diabetes mellitus (PNDM) is a rare condition presenting before six months of age. Mutations in the genes encoding the ATP-sensitive potassium (KATP) channel are the most common causes. Sulfonylurea (SU) therapy leads to dramatic improvement in diabetes control and quality of life in most patients who carry these mutations. Here, we report the long-term follow-up results of two siblings with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
